Innoviva, Inc.
INVA • NASDAQ
Innoviva, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Pavel Raifeld, with a market cap of $1.7B.
Market Cap$1.7B
Employees112.0
CEOPavel Raifeld
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 6, 2026 · In 1 weekBefore Market Open · Q1 2026
Financials
INV
Innoviva, Inc. FAQ
Common questions about Innoviva, Inc.
Innoviva, Inc. is scheduled to report earnings for Q1 2026 on May 6, 2026 before market open. Analysts estimate revenue of $101.6M.
Innoviva, Inc. has approximately 112 employees.